Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michele Albert, M.D.

Concepts (63)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brachytherapy7200712460.500 Why?
Gastrointestinal Hemorrhage3200711300.360 Why?
Rectal Diseases220071420.340 Why?
Rectum420079030.270 Why?
Urethra120034080.200 Why?
Prostatic Neoplasms72007110390.180 Why?
Urinary Bladder1200311710.150 Why?
Radiation Injuries1200311780.140 Why?
Carcinoma2200723740.130 Why?
Sarcoma, Synovial120061640.060 Why?
Urinary Retention120051100.060 Why?
Vulvar Neoplasms120062720.060 Why?
Radiotherapy Dosage2200728760.060 Why?
Adenocarcinoma3200663470.060 Why?
Radiation Protection120054190.050 Why?
Salvage Therapy1200712690.050 Why?
Radiotherapy, Intensity-Modulated120068060.040 Why?
Radiometry120058000.040 Why?
Prostate-Specific Antigen2200724580.040 Why?
Surgical Flaps1200616340.040 Why?
Magnetic Resonance Imaging42007353420.040 Why?
Radiotherapy Planning, Computer-Assisted1200516220.030 Why?
Prostatectomy1200318710.030 Why?
Neoadjuvant Therapy1200327210.030 Why?
Neoplasm Recurrence, Local1200791850.020 Why?
Aged620071629440.020 Why?
Middle Aged720072131270.020 Why?
Follow-Up Studies32007390040.020 Why?
Models, Biological1200595810.020 Why?
Male Urogenital Diseases12007480.020 Why?
Risk Assessment22007233200.020 Why?
Mesna12006660.020 Why?
Ifosfamide120062250.020 Why?
Antineoplastic Combined Chemotherapy Protocols12006114720.020 Why?
Aged, 80 and over22007576830.020 Why?
Numerical Analysis, Computer-Assisted120051250.020 Why?
Male720073495380.020 Why?
Body Burden120051580.020 Why?
Life Tables120033700.010 Why?
Relative Biological Effectiveness120053230.010 Why?
Computer Systems120034830.010 Why?
Doxorubicin1200622150.010 Why?
Organ Specificity1200520030.010 Why?
Intraoperative Care120037660.010 Why?
Humans820077420880.010 Why?
Gastrointestinal Diseases1200711670.010 Why?
Chemotherapy, Adjuvant1200634710.010 Why?
Prospective Studies32007531870.010 Why?
Kaplan-Meier Estimate1200765340.010 Why?
Neoplasm Invasiveness1200336120.010 Why?
Combined Modality Therapy1200686210.010 Why?
Acute Disease1200571410.010 Why?
Disease-Free Survival1200368910.010 Why?
Radiography1200370100.010 Why?
Computer Simulation1200561910.010 Why?
Sensitivity and Specificity12005147200.010 Why?
Risk Factors22007721450.010 Why?
Treatment Outcome22007629660.010 Why?
Proportional Hazards Models12003123440.010 Why?
Reproducibility of Results12005198620.000 Why?
Time Factors12007400540.000 Why?
Retrospective Studies12003770980.000 Why?
Female120063795920.000 Why?
Albert's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.